|Articles|September 1, 2001
- Applied Clinical Trials-09-01-2001
Randomized Controlled Trials
New systems of ethical oversight for randomized controlled trials could ease the problems caused by increasingly cumbersome restrictions.
Advertisement
Articles in this issue
over 24 years ago
Connecting at the Connectathonover 24 years ago
Patient Demands vs. Product Developmentover 24 years ago
EU Proposes Authorization Changesover 24 years ago
FDA Warning Lettersover 24 years ago
The Clinical Audit in Pharmaceutical Developmentover 24 years ago
What a Form 483 Really Meansover 24 years ago
Effective Invvestigator Meetingsover 24 years ago
A New Challange for Central Laboratoriesover 24 years ago
Domenico Criscuoloover 24 years ago
Monitoring Where Others Take HolidaysNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA
3
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
4
ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
